JXL069 is an experimental drug originally developed at the University of California, Los Angeles (UCLA), that functions as a potent and highly selective mitochondrial pyruvate carrier (MPC) inhibitor, effectively disrupting the regulated import of pyruvate into mitochondria, altering cellular energy metabolism, and demonstrating promising preclinical efficacy as a metabolic modulator in androgenetic alopecia through mechanistic validation in animal model studies.
Molecular Weight:
439.31
Purity:
99.99%
CAS Number:
[2260696-63-5]
Formula:
C20H11F6N3O2
Target:
Others
T211169
* VAT and and shipping costs not included. Errors and price changes excepted
